"Cyclooxygenase 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A constitutively-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes.
| Descriptor ID |
D051545
|
| MeSH Number(s) |
D08.811.600.720.500
|
| Concept/Terms |
Cyclooxygenase 1- Cyclooxygenase 1
- Cyclo-Oxygenase I
- Cyclo Oxygenase I
- Prostaglandin H Synthase-1
- Prostaglandin H Synthase 1
- COX-1 Prostaglandin Synthase
- COX 1 Prostaglandin Synthase
- Prostaglandin Synthase, COX-1
- Synthase, COX-1 Prostaglandin
- Cyclooxygenase-1
|
Below are MeSH descriptors whose meaning is more general than "Cyclooxygenase 1".
Below are MeSH descriptors whose meaning is more specific than "Cyclooxygenase 1".
This graph shows the total number of publications written about "Cyclooxygenase 1" by people in this website by year, and whether "Cyclooxygenase 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 2 | 3 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cyclooxygenase 1" by people in Profiles.
-
A Network Pharmacology Study to Uncover the Multiple Molecular Mechanism of the Chinese Patent Medicine Toujiequwen Granules in the Treatment of Corona Virus Disease 2019 (COVID-19). Curr Med Sci. 2021 Apr; 41(2):297-305.
-
DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1. Sci Rep. 2020 06 23; 10(1):10187.
-
Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome. Am J Cardiovasc Drugs. 2018 Dec; 18(6):457-472.
-
Suberanilohydroxamic acid prevents TGF-ß1-induced COX-2 repression in human lung fibroblasts post-transcriptionally by TIA-1 downregulation. Biochim Biophys Acta Gene Regul Mech. 2018 May; 1861(5):463-472.
-
Kinetic basis for the activation of human cyclooxygenase-2 rather than cyclooxygenase-1 by nitric oxide. Org Biomol Chem. 2018 01 31; 16(5):765-770.
-
Association between PTGS1 polymorphisms and functional outcomes in Chinese patients with stroke during aspirin therapy: Interaction with smoking. J Neurol Sci. 2017 May 15; 376:211-215.
-
Selective cyclooxygenase-2 inhibitors development in cardiovascular medicine. Circulation. 2005 Aug 16; 112(7):1073-9.